Drugs / PPI-1011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05969977 | May → Nov 2023 | rhizomelic chondrodysplasia punctata | MED-LIFE DISCOVERIES LP | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PPI-1011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05969977 ↗ |
| Modality | Small molecule | — CHEMBL6068521 ↗ |
| Route | Oral | “PPI-1011 administered orally to healthy subjects” NCT05969977 ↗ |